WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY

Saved in:
Bibliographic Details
Main Authors: Dmitrij Kollins, Olympia Papachristofi, Thomas Hach, Severina Jacinto-Sanders, Tobias Merkel, Ronny Renfurm, Vlado Perkovic
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924023854
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849690934785081344
author Dmitrij Kollins
Olympia Papachristofi
Thomas Hach
Severina Jacinto-Sanders
Tobias Merkel
Ronny Renfurm
Vlado Perkovic
author_facet Dmitrij Kollins
Olympia Papachristofi
Thomas Hach
Severina Jacinto-Sanders
Tobias Merkel
Ronny Renfurm
Vlado Perkovic
author_sort Dmitrij Kollins
collection DOAJ
format Article
id doaj-art-ccea8e19a1ba4211831178d60b3ff42e
institution DOAJ
issn 2468-0249
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-ccea8e19a1ba4211831178d60b3ff42e2025-08-20T03:21:11ZengElsevierKidney International Reports2468-02492025-02-01102S18410.1016/j.ekir.2024.11.363WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDYDmitrij Kollins0Olympia Papachristofi1Thomas Hach2Severina Jacinto-Sanders3Tobias Merkel4Ronny Renfurm5Vlado Perkovic6Cardio-Renal-Metabolic GDD, Novartis Pharma AG, Basel, SwitzerlandCardio-Renal-Metabolic GDD, Novartis Pharma AG, Basel, SwitzerlandCardio-Renal-Metabolic GDD, Novartis Pharma AG, Basel, SwitzerlandCardio-Renal-Metabolic GDD, Novartis Pharma AG, Basel, SwitzerlandCardio-Renal-Metabolic GDD, Novartis Pharma AG, Basel, SwitzerlandCardio-Renal-Metabolic GDD, Novartis Pharma AG, Basel, SwitzerlandRenal and Metabolic Division, University of New South Wales, Sydney, Australiahttp://www.sciencedirect.com/science/article/pii/S2468024924023854
spellingShingle Dmitrij Kollins
Olympia Papachristofi
Thomas Hach
Severina Jacinto-Sanders
Tobias Merkel
Ronny Renfurm
Vlado Perkovic
WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
Kidney International Reports
title WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
title_full WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
title_fullStr WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
title_full_unstemmed WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
title_short WCN25-799 EFFICACY AND SAFETY OF IPTACOPAN IN PATIENTS WITH IgA NEPHROPATHY (IgAN): INTERIM ANALYSIS (IA) OF THE PHASE 3 APPLAUSE-IgAN STUDY
title_sort wcn25 799 efficacy and safety of iptacopan in patients with iga nephropathy igan interim analysis ia of the phase 3 applause igan study
url http://www.sciencedirect.com/science/article/pii/S2468024924023854
work_keys_str_mv AT dmitrijkollins wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy
AT olympiapapachristofi wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy
AT thomashach wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy
AT severinajacintosanders wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy
AT tobiasmerkel wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy
AT ronnyrenfurm wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy
AT vladoperkovic wcn25799efficacyandsafetyofiptacopaninpatientswithiganephropathyiganinterimanalysisiaofthephase3applauseiganstudy